68 related articles for article (PubMed ID: 21261475)
1. LMWH bemiparin and ULMWH RO-14 reduce the endothelial angiogenic features elicited by leukemia, lung cancer, or breast cancer cells.
Vignoli A; Marchetti M; Russo L; Cantalino E; Diani E; Bonacina G; Falanga A
Cancer Invest; 2011 Feb; 29(2):153-61. PubMed ID: 21261475
[TBL] [Abstract][Full Text] [Related]
2. Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparin.
Marchetti M; Vignoli A; Russo L; Balducci D; Pagnoncelli M; Barbui T; Falanga A
Thromb Res; 2008; 121(5):637-45. PubMed ID: 17692905
[TBL] [Abstract][Full Text] [Related]
3. Low-molecular-weight heparins and angiogenesis.
Norrby K
APMIS; 2006 Feb; 114(2):79-102. PubMed ID: 16519745
[TBL] [Abstract][Full Text] [Related]
4. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.
Chintalapati M; Truax R; Stout R; Portier R; Losso JN
J Agric Food Chem; 2009 Jun; 57(12):5201-10. PubMed ID: 19476359
[TBL] [Abstract][Full Text] [Related]
6. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
Wood JM
Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
[TBL] [Abstract][Full Text] [Related]
8. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
[TBL] [Abstract][Full Text] [Related]
9. SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro.
Abdollahi A; Lipson KE; Han X; Krempien R; Trinh T; Weber KJ; Hahnfeldt P; Hlatky L; Debus J; Howlett AR; Huber PE
Cancer Res; 2003 Jul; 63(13):3755-63. PubMed ID: 12839971
[TBL] [Abstract][Full Text] [Related]
10. Low molecular weight fucoidan and heparin enhance the basic fibroblast growth factor-induced tube formation of endothelial cells through heparan sulfate-dependent alpha6 overexpression.
Chabut D; Fischer AM; Colliec-Jouault S; Laurendeau I; Matou S; Le Bonniec B; Helley D
Mol Pharmacol; 2003 Sep; 64(3):696-702. PubMed ID: 12920206
[TBL] [Abstract][Full Text] [Related]
11. Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor.
Morais C; Gobe G; Johnson DW; Healy H
Angiogenesis; 2009; 12(4):365-79. PubMed ID: 19882112
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of fondaparinux and bemiparin on angiogenic and vasculogenesis-like processes.
Da Pozzo E; Barsotti MC; Bendinelli S; Martelli A; Calderone V; Balbarini A; Martini C; Di Stefano R
Thromb Res; 2012 Sep; 130(3):e113-22. PubMed ID: 22497885
[TBL] [Abstract][Full Text] [Related]
13. Phosphomimetic mutants of pigment epithelium-derived factor with enhanced antiangiogenic activity as potent anticancer agents.
Konson A; Pradeep S; Seger R
Cancer Res; 2010 Aug; 70(15):6247-57. PubMed ID: 20610633
[TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenic effects and mechanisms of polysaccharides from Antrodia cinnamomea with different molecular weights.
Yang CM; Zhou YJ; Wang RJ; Hu ML
J Ethnopharmacol; 2009 Jun; 123(3):407-12. PubMed ID: 19501273
[TBL] [Abstract][Full Text] [Related]
15. Effects of thalidomide on the expression of angiogenesis growth factors in human A549 lung adenocarcinoma cells.
Li X; Liu X; Wang J; Wang Z; Jiang W; Reed E; Zhang Y; Liu Y; Li QQ
Int J Mol Med; 2003 Jun; 11(6):785-90. PubMed ID: 12736723
[TBL] [Abstract][Full Text] [Related]
16. A novel compound, NP-184, inhibits the vascular endothelial growth factor induced angiogenesis.
Lin KT; Lien JC; Chung CH; Kuo SC; Huang TF
Eur J Pharmacol; 2010 Mar; 630(1-3):53-60. PubMed ID: 20067787
[TBL] [Abstract][Full Text] [Related]
17. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus.
Del Bufalo D; Ciuffreda L; Trisciuoglio D; Desideri M; Cognetti F; Zupi G; Milella M
Cancer Res; 2006 Jun; 66(11):5549-54. PubMed ID: 16740688
[TBL] [Abstract][Full Text] [Related]
19. A novel in vitro assay for human angiogenesis.
Brown KJ; Maynes SF; Bezos A; Maguire DJ; Ford MD; Parish CR
Lab Invest; 1996 Oct; 75(4):539-55. PubMed ID: 8874385
[TBL] [Abstract][Full Text] [Related]
20. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
